Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
High dose methotrexate (MTX) is used in therapy of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients. It acts as competitive inhibitor of dihydrofolate reductase and consequently inhibits synthesis of deoxyribonucleic acid. The bioavailability is dependent upon dose and rou...
保存先:
主要な著者: | Škorić Biljana (著者), Jovanović Marija (著者), Miljković Branislava (著者), Kuzmanović Miloš (著者), Vučićević Katarina (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2020-01-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Pediatric pharmacokinetic considerations and implications for drug dosing
著者:: Jovanović Marija, 等
出版事項: (2022) -
Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
著者:: Xuan Gao, 等
出版事項: (2021) -
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma
著者:: Amandeep Aujla, 等
出版事項: (2019) -
Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
著者:: Roganović Maša, 等
出版事項: (2021) -
Assessment of clinical immunogenicity of inotuzumab ozogamicin in patients with non-Hodgkin lymphoma and acute lymphoblastic leukemia
著者:: Darshana Jani, 等
出版事項: (2018)